By Allissa Wickham ( July 7, 2014, 7:22 PM EDT) -- Generic drug producer Novel Laboratories Inc. urged the Federal Circuit on Thursday to deny Braintree Laboratories Inc.'s bid for an en banc rehearing on the construction of the term "a patient" in its Suprep colon cleanser patent, saying the court properly rendered the claim to mean a "patient population."...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.